Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of MXN 3.23 trillion. The enterprise value is 4.05 trillion.

Market Cap	3.23T
Enterprise Value	4.05T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 21, 2025

Share Statistics

Current Share Class	538.48M
Shares Outstanding	n/a
Shares Change (YoY)	+0.28%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.83%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 25.15 and the forward PE ratio is 15.92.

PE Ratio	25.15
Forward PE	15.92
PS Ratio	4.90
PB Ratio	18.32
P/TBV Ratio	n/a
P/FCF Ratio	15.27
P/OCF Ratio	13.42
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 19.15.

EV / Earnings	31.55
EV / Sales	6.19
EV / EBITDA	13.35
EV / EBIT	19.96
EV / FCF	19.15

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.

Current Ratio	1.28
Quick Ratio	0.82
Debt / Equity	5.67
Debt / EBITDA	3.27
Debt / FCF	4.73
Interest Coverage	3.32

Financial Efficiency

Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE)	81.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	10.56%
Return on Capital Employed (ROCE)	16.33%
Revenue Per Employee	23.56M
Profits Per Employee	4.59M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.57

Taxes

In the past 12 months, Amgen has paid 22.73 billion in taxes.

Income Tax	22.73B
Effective Tax Rate	15.03%

Stock Price Statistics

The stock price has increased by +7.17% in the last 52 weeks. The beta is 0.46, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+7.17%
50-Day Moving Average	5,556.55
200-Day Moving Average	5,191.40
Relative Strength Index (RSI)	62.58
Average Volume (20 Days)	552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.09

Income Statement

In the last 12 months, Amgen had revenue of MXN 659.79 billion and earned 128.49 billion in profits. Earnings per share was 237.23.

Revenue	659.79B
Gross Profit	462.19B
Operating Income	204.70B
Pretax Income	151.21B
Net Income	128.49B
EBITDA	302.30B
EBIT	204.70B
Earnings Per Share (EPS)	237.23

Full Income Statement

Balance Sheet

The company has 173.24 billion in cash and 1.00 trillion in debt, giving a net cash position of -828.00 billion.

Cash & Cash Equivalents	173.24B
Total Debt	1.00T
Net Cash	-828.00B
Net Cash Per Share	n/a
Equity (Book Value)	176.43B
Book Value Per Share	327.64
Working Capital	111.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 240.76 billion and capital expenditures -29.11 billion, giving a free cash flow of 211.65 billion.

Operating Cash Flow	240.76B
Capital Expenditures	-29.11B
Free Cash Flow	211.65B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.05%, with operating and profit margins of 31.02% and 19.47%.

Gross Margin	70.05%
Operating Margin	31.02%
Pretax Margin	22.92%
Profit Margin	19.47%
EBITDA Margin	45.82%
EBIT Margin	31.02%
FCF Margin	32.08%

Dividends & Yields

This stock pays an annual dividend of 183.45, which amounts to a dividend yield of 2.96%.

Dividend Per Share	183.45
Dividend Yield	2.96%
Dividend Growth (YoY)	11.99%
Years of Dividend Growth	1
Payout Ratio	72.03%
Buyback Yield	-0.28%
Shareholder Yield	2.68%
Earnings Yield	3.98%
FCF Yield	6.55%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.69 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.69
Piotroski F-Score	7